Phase II study of panitumumab combined with capecitabine and oxaliplatin as first-line treatment in metastatic colorectal cancer patients: clinical results including extended tumor genotyping

2018 ◽  
Vol 35 (7) ◽  
Author(s):  
George Papaxoinis ◽  
Vassiliki Kotoula ◽  
Eleni Giannoulatou ◽  
Georgia-Angeliki Koliou ◽  
Vasilios Karavasilis ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Metastatic Colorectal Cancer ◽  
Cancer Patients ◽  
Phase Ii Study ◽  
Clinical Results ◽  
Line Treatment ◽  
First Line ◽  
Colorectal Cancer Patients ◽  
Tumor Genotyping ◽  
First Line Treatment

scholarly journals IL-8 and eNOS polymorphisms predict bevacizumab-based first line treatment outcomes in RAS mutant metastatic colorectal cancer patients

Oncotarget ◽  
2017 ◽  
Vol 8 (10) ◽  
pp. 16887-16898 ◽  
Author(s):  
Mariantonietta Di Salvatore ◽  
Filippo Pietrantonio ◽  
Armando Orlandi ◽  
Marzia Del Re ◽  
Rosa Berenato ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Metastatic Colorectal Cancer ◽  
Treatment Outcomes ◽  
Cancer Patients ◽  
Line Treatment ◽  
First Line ◽  
Colorectal Cancer Patients ◽  
Enos Polymorphisms ◽  
First Line Treatment
Sign in / Sign up

Export Citation Format

Share Document